RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications
Antonio Garcia-Gomez, Enrique M. Ocio, Atanasio Pandiella, Jesús F. San Miguel, Mercedes GarayoaVolume:
31
Language:
english
DOI:
10.1007/s10637-012-9845-3
Date:
February, 2013
File:
PDF, 299 KB
english, 2013